Company: PTPI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001410578-25-001349
Chunk: 12

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 5O
Chunk 12
---
ITEM 5. OTHER INFORMATION.

On May 12, 2025, the Board (i) increased the annual base salary for Fady Boctor, the Company’s President and Chief Commercial Officer, from $280,000 to $350,000, less all applicable withholdings and deductions, effective June 1, 2025. In addition, on May 12, 2025, in consideration of the work done in connection with the Company’s recent financings and planned corporate restructuring, the Board approved special bonuses to certain directors and officer of the Company, including Mr. Boctor and Mitchell Arnold, the Company’s Vice President of Finance and Chief Accounting Officer, in the amount of $50,000 and $25,000, respectively.

​